Concurrent and future risk of endometrial cancer in women with endometrial hyperplasia: A systematic review and meta-analysis.
Michelle T DohertyOmolara B SanniHelen G ColemanChris R CardwellW Glenn McCluggageDeclan QuinnJames WylieÚna C Mc MenaminPublished in: PloS one (2020)
Overall, a third of women with atypical hyperplasia had concurrent endometrial cancer, although the number of studies, especially population-based, is small. Progression to cancer in atypical hyperplasia was high, but few studies were identified. Population-based estimates are required, in both atypical and non-atypical hyperplasia patients to better inform treatment strategies.